Literature DB >> 11346465

A novel amplicon at 9p23 - 24 in squamous cell carcinoma of the esophagus that lies proximal to GASC1 and harbors NFIB.

Z Q Yang1, I Imoto, A Pimkhaokham, Y Shimada, K Sasaki, M Oka, J Inazawa.   

Abstract

The non-random amplification of DNA at 9p23 - 24 observed in various types of human cancers, including esophageal squamous cell carcinomas (ESCs), may reflect the locations of important tumor-associated genes. Our previous studies using ESC cell lines defined an amplicon in this region and identified a novel gene, GASC1, as a target of the amplification. Since different regions within the same chromosome arm are often involved in amplification in a syntenic or non-syntenic manner, we characterized the amplicon at 9p23 - 24 in 35 ESC cell lines (29 KYSE series and 6 YES series), and examined possible involvement of non-syntenic amplifications at 9p23 - 24 in 32 primary ESCs. Our results clearly indicated that two target regions for DNA amplification exist at 9p23 - 24; the major amplicon contains GASC1, and the minor one harbors a transcription factor, NFIB, centromeric to the GASC1 locus.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11346465      PMCID: PMC5926726          DOI: 10.1111/j.1349-7006.2001.tb01112.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  33 in total

1.  Cytogenetic analysis of esophageal squamous cell carcinoma cell lines by comparative genomic hybridization: relationship of cytogenetic aberrations to in vitro cell growth.

Authors:  K Tada; M Oka; H Hayashi; A Tangoku; A Oga; K Sasaki
Journal:  Cancer Genet Cytogenet       Date:  2000-03

2.  Retention of polysomy at 9p23-24 during karyotypic evolution in human breast cancer cell line COLO 824.

Authors:  L Savelyeva; A Claas; H An; R G Weber; P Lichter; M Schwab
Journal:  Genes Chromosomes Cancer       Date:  1999-01       Impact factor: 5.006

3.  Identification of a novel gene, MASL1, within an amplicon at 8p23.1 detected in malignant fibrous histiocytomas by comparative genomic hybridization.

Authors:  T Sakabe; T Shinomiya; T Mori; Y Ariyama; Y Fukuda; T Fujiwara; Y Nakamura; J Inazawa
Journal:  Cancer Res       Date:  1999-02-01       Impact factor: 12.701

4.  A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines.

Authors:  S Sen; H Zhou; R A White
Journal:  Oncogene       Date:  1997-05-08       Impact factor: 9.867

5.  Clonal origin of Philadelphia chromosome negative cells with trisomy 8 appearing during the course of alpha-interferon therapy for Ph positive chronic myelocytic leukemia.

Authors:  T Ariyama; J Inazawa; Y Uemura; N Kakazu; T Maekawa; F Urase; K Irimajiri; A Horiuchi; Y Nakamura; T Abe
Journal:  Cancer Genet Cytogenet       Date:  1995-05

6.  Localization of PS6K to chromosomal region 17q23 and determination of its amplification in breast cancer.

Authors:  F J Couch; X Y Wang; G J Wu; J Qian; R B Jenkins; C D James
Journal:  Cancer Res       Date:  1999-04-01       Impact factor: 12.701

7.  Characterization of double minute chromosomes' DNA content in a human high grade astrocytoma cell line by using comparative genomic hybridization and fluorescence in situ hybridization.

Authors:  M Giollant; S Bertrand; P Verrelle; A Tchirkov; S du Manoir; T Ried; F Mornex; J F Doré; T Cremer; P Malet
Journal:  Hum Genet       Date:  1996-09       Impact factor: 4.132

8.  DNA amplifications on chromosomes 7, 9 and 12 in glioblastoma detected by reverse chromosome painting.

Authors:  U Fischer; B Wullich; H P Sattler; E Göttert; K D Zang; E Meese
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

9.  Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma.

Authors:  C Collins; J M Rommens; D Kowbel; T Godfrey; M Tanner; S I Hwang; D Polikoff; G Nonet; J Cochran; K Myambo; K E Jay; J Froula; T Cloutier; W L Kuo; P Yaswen; S Dairkee; J Giovanola; G B Hutchinson; J Isola; O P Kallioniemi; M Palazzolo; C Martin; C Ericsson; D Pinkel; D Albertson; W B Li; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

10.  Nonrandom chromosomal imbalances in esophageal squamous cell carcinoma cell lines: possible involvement of the ATF3 and CENPF genes in the 1q32 amplicon.

Authors:  A Pimkhaokham; Y Shimada; Y Fukuda; N Kurihara; I Imoto; Z Q Yang; M Imamura; Y Nakamura; T Amagasa; J Inazawa
Journal:  Jpn J Cancer Res       Date:  2000-11
View more
  14 in total

Review 1.  Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease.

Authors:  Paul A C Cloos; Jesper Christensen; Karl Agger; Kristian Helin
Journal:  Genes Dev       Date:  2008-05-01       Impact factor: 11.361

Review 2.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

3.  Nuclear factor one transcription factors in CNS development.

Authors:  Sharon Mason; Michael Piper; Richard M Gronostajski; Linda J Richards
Journal:  Mol Neurobiol       Date:  2008-12-05       Impact factor: 5.590

4.  The oncogenic role of GASC1 in chemically induced mouse skin cancer.

Authors:  Yumi Ozaki; Kyoko Fujiwara; Maki Ikeda; Toshinori Ozaki; Tadashi Terui; Masayoshi Soma; Johji Inazawa; Hiroki Nagase
Journal:  Mamm Genome       Date:  2015-08-07       Impact factor: 2.957

Review 5.  Cancer and altered metabolism: potential importance of hypoxia-inducible factor and 2-oxoglutarate-dependent dioxygenases.

Authors:  W G Kaelin
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2011-11-16

6.  Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy.

Authors:  C Thirlwell; Lke Schulz; Hk Dibra; S Beck
Journal:  Clin Epigenetics       Date:  2011-12-05       Impact factor: 6.551

7.  Regulation of adipogenesis by nuclear receptor PPARγ is modulated by the histone demethylase JMJD2C.

Authors:  Fernando Lizcano; Carolina Romero; Diana Vargas
Journal:  Genet Mol Biol       Date:  2011-03-01       Impact factor: 1.771

8.  Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer.

Authors:  G Liu; A Bollig-Fischer; B Kreike; M J van de Vijver; J Abrams; S P Ethier; Z-Q Yang
Journal:  Oncogene       Date:  2009-09-28       Impact factor: 9.867

9.  A human Myogenin promoter modified to be highly active in alveolar rhabdomyosarcoma drives an effective suicide gene therapy.

Authors:  Johanna Pruller; Isabella Hofer; Massimo Ganassi; Philipp Heher; Michelle T Ma; Peter S Zammit
Journal:  Cancer Gene Ther       Date:  2020-09-25       Impact factor: 5.987

10.  A three-gene signature and clinical outcome in esophageal squamous cell carcinoma.

Authors:  Ling-Ling Sun; Jian-Yi Wu; Zhi-Yong Wu; Jin-Hui Shen; Xiu-E Xu; Bo Chen; Shao-Hong Wang; En-Min Li; Li-Yan Xu
Journal:  Int J Cancer       Date:  2014-09-24       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.